Testing effectiveness (Phase 2)UnknownNCT05853471
What this trial is testing
[18F]MC225-PET in Neurodegenerative Disease
Who this might be right for
Neurodegenerative DiseasesAlzheimer DiseaseParkinson Disease+1 more
University Medical Center Groningen 30